Insiders · Profile

Moscato Robert Jr.

COO at Avalo Therapeutics. Filing since 4 Dec 2017. CIK 0001723420

Company

Date

Role

Action

Shares

Amount

Of holding

AVTX Avalo Therapeutics, Inc.

4 Dec 2017

COO

Bought

285

$504.45

0.0%

1 decision on file.